Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	115.08	34.81	29.43	39.14	43.84	11.23
Short-Term Investments	708.77	388.78	275.52	369.11	150.59	53.15
Cash & Short-Term Investments	823.85	423.6	304.95	408.25	194.42	64.38
Cash Growth	195.94%	38.91%	-25.30%	109.98%	201.98%	-31.52%
Receivables	2.67	2.63	0.35	0.17	1.8	1.02
Prepaid Expenses	8.81	5.47	12.39	2.42	1.62	1.3
Total Current Assets	835.32	431.69	317.69	410.84	197.84	66.7
Property, Plant & Equipment	6.23	6.64	7.75	6.52	7.26	7.5
Other Intangible Assets	27.19	27.19	27.19	27.19	30.69	48.69
Other Long-Term Assets	0.11	0.11	0.1	0.1	0.04	0.04
Total Assets	868.85	465.63	352.74	444.65	235.84	122.93
Accounts Payable	3.23	3.49	3.34	1.23	1.05	1.17
Accrued Expenses	17.54	22.03	12.84	12	8.46	6.5
Current Portion of Leases	1.64	1.61	1.45	1.75	1.33	1.94
Current Unearned Revenue	-	3.06	0.06	0.43	-	-
Other Current Liabilities	3.88	0.93	0.93	1.12	3.37	2.03
Total Current Liabilities	26.29	31.13	18.61	16.53	14.21	11.64
Long-Term Leases	0.47	0.93	2.59	1.3	2.15	1.71
Other Long-Term Liabilities	3.47	4.4	5.33	7.35	10.12	15.55
Total Liabilities	30.23	36.46	26.53	25.18	26.48	28.91
Common Stock	0.07	0.06	0.05	0.05	0.04	0.02
Additional Paid-In Capital	2,266	1,823	1,581	1,561	1,280	1,105
Retained Earnings	-1,430.17	-1,397.36	-1,255.93	-1,143.61	-1,073.1	-1,013.32
Comprensive Income & Other	2.24	3.31	1.26	1.89	2.59	2.62
Shareholders' Equity	838.61	429.17	326.2	419.48	209.36	94.03
Total Liabilities & Equity	868.85	465.63	352.74	444.65	235.84	122.93
Total Debt	2.11	2.54	4.03	3.04	3.48	3.66
Net Cash (Debt)	821.73	421.06	300.92	405.21	190.94	60.73
Net Cash Growth	199.10%	39.92%	-25.74%	112.22%	214.43%	-35.41%
Net Cash Per Share	16.00	8.69	6.42	9.45	6.44	4.19
Filing Date Shares Outstanding	65.91	55.9	47.21	46.74	39.61	17.57
Total Common Shares Outstanding	65.91	55.88	47.2	46.73	39.6	16.97
Working Capital	809.03	400.57	299.08	394.31	183.64	55.06
Book Value Per Share	12.72	7.68	6.91	8.98	5.29	5.54
Tangible Book Value	811.42	401.98	299.01	392.29	178.67	45.34
Tangible Book Value Per Share	12.31	7.19	6.33	8.39	4.51	2.67
Machinery	-	16.01	15.26	14.51	14.61	15.01
Construction In Progress	-	0.79	0.5	0.63	0.34	0.19
Leasehold Improvements	-	9.65	9.61	9.53	10.1	17.24

Source: S&P Capital IQ. Standard template.